|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1523 News |
|
| «12...19202122232425262728293031» |
- Enrollment change: A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B (clinicaltrials.gov) - Apr 21, 2012
P=N/A, N=0, Withdrawn, Sponsor: Kirby Institute
N=1000 --> 0
- || New P3 trial: Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine (clinicaltrials.gov) - Apr 16, 2012
P3, N=900, Completed, Sponsor: Jiangsu Province Centers for Disease Control and Prevention
- | Trial completion: Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children (clinicaltrials.gov) - Apr 16, 2012
P3, N=2394, Completed, Sponsor: Jiangsu Province Centers for Disease Control and Prevention
N=1000 --> 0 Active, not recruiting --> Completed
- ||||| FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
New P4 trial: A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults (clinicaltrials.gov) - Apr 16, 2012
P4, N=303, Completed, Sponsor: MedImmune LLC
- Trial completion: COFLUPREG: "COhort Study on A/H1N1 FLU During PREGnancy" (clinicaltrials.gov) - Apr 15, 2012
P=N/A, N=919, Completed, Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi
Trial completion: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. (clinicaltrials.gov) - Apr 12, 2012
P3, N=370, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Foclivia (adjuvanted egg-based influenza A (H5N1) vaccine) / CSL Behring
Trial termination: H1N1sw Vaccine in Adult Transplant Recipients (clinicaltrials.gov) - Apr 12, 2012
P2, N=13, Terminated, Sponsor: HepNet Study House, German Liverfoundation
Active, not recruiting --> Completed Active, not recruiting --> Terminated; End of H1N1 Swine Flu Pandemic
- Foclivia (adjuvanted egg-based influenza A (H5N1) vaccine) / CSL Behring
Enrollment change: H1N1sw Vaccine in Adult Transplant Recipients (clinicaltrials.gov) - Apr 12, 2012
P2, N=13, Terminated, Sponsor: HepNet Study House, German Liverfoundation
Active, not recruiting --> Terminated; End of H1N1 Swine Flu Pandemic N=120 --> 13
- ||| Trial completion: A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects (clinicaltrials.gov) - Apr 12, 2012
P=N/A, N=1206, Completed, Sponsor: Omninvest Vaccine Manufacturing, Researching and Trading Ltd.
N=120 --> 13 Active, not recruiting --> Completed
- FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
Trial completion: Fluad Tx: Seasonal Flu Vaccine in Adult Transplant Recipients (clinicaltrials.gov) - Apr 12, 2012
P2, N=122, Completed, Sponsor: HepNet Study House, German Liverfoundation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households (clinicaltrials.gov) - Apr 11, 2012
P=N/A, N=6069, Completed, Sponsor: Centers for Disease Control and Prevention
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: FLU-FIT Program at Kaiser Permanente Northern California (clinicaltrials.gov) - Apr 9, 2012
P=N/A, N=7465, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Completed
- Trial completion: MCSkipp: School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities (clinicaltrials.gov) - Apr 2, 2012
P=N/A, N=25366, Completed, Sponsor: Monroe County Department of Public Health
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Influenza Vaccine in HIV Infected Children (clinicaltrials.gov) - Apr 1, 2012
P4, N=412, Completed, Sponsor: University of Witwatersrand, South Africa
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: MI GIFT: Maternal Immunization: Giving Immunity For Tomorrow (clinicaltrials.gov) - Mar 31, 2012
P=N/A, N=300, Recruiting, Sponsor: University of Utah
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Infectivity of Norovirus in Groundwater-Human Challenge Study (clinicaltrials.gov) - Mar 29, 2012
P=N/A, N=13, Completed, Sponsor: Emory University
Not yet recruiting --> Recruiting N=20 --> 13
- ||| Fluarix (Influenza virus trivalent vaccine) / GSK
Clinical: Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine (clinicaltrials.gov) - Mar 29, 2012
P=N/A, N=600, Completed, Sponsor: Hualan Biological Engineering, Inc.
- Trial completion: Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study (clinicaltrials.gov) - Mar 29, 2012
P=N/A, N=51, Completed, Sponsor: Emory University
N=20 --> 13 Active, not recruiting --> Completed
- Trial completion: Infectivity of Norovirus in Groundwater-Human Challenge Study (clinicaltrials.gov) - Mar 29, 2012
P=N/A, N=13, Completed, Sponsor: Emory University
Active, not recruiting --> Completed Suspended --> Completed
- | Trial completion: Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza (clinicaltrials.gov) - Mar 29, 2012
P1, N=40, Completed, Sponsor: Theraclone Sciences, Inc.
Suspended --> Completed Recruiting --> Completed
- sirolimus / Generic mfg.
Trial completion: PIP-02: Protective Immunity Project 02 (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=97, Completed, Sponsor: Emory University
Recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1 (clinicaltrials.gov) - Mar 27, 2012
P2, N=0, Withdrawn, Sponsor: Instituto Nacional de Salud Publica, Mexico
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Trial initiation date: Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1 (clinicaltrials.gov) - Mar 27, 2012
P2, N=0, Withdrawn, Sponsor: Instituto Nacional de Salud Publica, Mexico
Not yet recruiting --> Withdrawn Initiation date: Nov 2009 --> Jun 2010
- Enrollment change: Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1 (clinicaltrials.gov) - Mar 27, 2012
P2, N=0, Withdrawn, Sponsor: Instituto Nacional de Salud Publica, Mexico
Initiation date: Nov 2009 --> Jun 2010 N=360 --> 0
- |||| Zadaxin (thymalfasin) / SciClone
Trial completion: A Pilot Study to Evaluate ZADAXIN's (clinicaltrials.gov) - Mar 27, 2012
P2, N=120, Completed, Sponsor: sigma-tau i.f.r. S.p.A.
N=360 --> 0 Active, not recruiting --> Completed
- |||| tofacitinib / Generic mfg.
Pneumococcal vaccines: A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo (clinicaltrials.gov) - Mar 22, 2012
P2, N=223, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine (clinicaltrials.gov) - Mar 22, 2012
P1, N=49, Completed, Sponsor: Immune Targeting Systems Ltd
Recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: High Dose Influenza in Immunosuppressed Subjects (clinicaltrials.gov) - Mar 21, 2012
P2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Terminated --> Withdrawn
- ||||| pimodivir (JNJ-3872) / J&J
New P2 trial: A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus (clinicaltrials.gov) - Mar 21, 2012
P2, N=140, Completed, Sponsor: Vertex Pharmaceuticals Incorporated
- ||||| New P2 trial: A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults (clinicaltrials.gov) - Mar 21, 2012
P2, N=500, Completed, Sponsor: Novavax
- Enrollment closed: VIP-H1N1: Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (clinicaltrials.gov) - Mar 21, 2012
P2, N=450, Active, not recruiting, Sponsor: Oswaldo Cruz Foundation
Terminated --> Withdrawn Recruiting --> Active, not recruiting
- Enrollment closed: Influenza and Text Messaging in Pregnancy (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=250, Active, not recruiting, Sponsor: University of Pittsburgh
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Trial completion: Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults (clinicaltrials.gov) - Mar 20, 2012
P2, N=467, Completed, Sponsor: Novavax
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Trial completion: Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) (clinicaltrials.gov) - Mar 20, 2012
P2, N=221, Completed, Sponsor: Novavax
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults (clinicaltrials.gov) - Mar 20, 2012
P2, N=317, Completed, Sponsor: Novavax
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: Safety, Reactogenicity and Immunogenicity of an H5N1 VLP (clinicaltrials.gov) - Mar 20, 2012
P1/2, N=230, Completed, Sponsor: Novavax
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| New P1 trial: Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years (clinicaltrials.gov) - Mar 20, 2012
P1, N=200, Completed, Sponsor: VaxInnate Corporation
- Enrollment closed: Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=140, Active, not recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: Novartis H1N1 Vaccine in Pregnant Women (clinicaltrials.gov) - Mar 14, 2012
P2, N=84, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting N=300 --> 84
- |||||||||| Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P3 trial: Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use) (clinicaltrials.gov) - Mar 13, 2012
P3, N=810, Completed, Sponsor: Hualan Biological Engineering, Inc.
- |||||||||| New P3 trial: Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation) (clinicaltrials.gov) - Mar 13, 2012
P3, N=900, Completed, Sponsor: Hualan Biological Engineering, Inc.
- || Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
New P3 trial, Combination therapy: Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) (clinicaltrials.gov) - Mar 12, 2012
P3, N=284, Completed, Sponsor: Sanofi Pasteur MSD
- ||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial initiation date: Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza (clinicaltrials.gov) - Mar 11, 2012
P3, N=3009, Completed, Sponsor: MedImmune LLC
N=300 --> 84 Initiation date: Feb 2001 --> Mar 2002
- || Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P3 trial: The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) ?Children Forms of Drug? (clinicaltrials.gov) - Mar 8, 2012
P3, N=1200, Recruiting, Sponsor: Chinese Academy of Medical Sciences
- || Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P3 trial: The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (clinicaltrials.gov) - Mar 7, 2012
P3, N=1200, Recruiting, Sponsor: Chinese Academy of Medical Sciences
- Enrollment change: Effects of Interscalene Brachial Plexus Nerve Blocks on the Hand and Forearm (clinicaltrials.gov) - Mar 5, 2012
P=N/A, N=62, Completed, Sponsor: University of California, San Diego
Initiation date: Feb 2001 --> Mar 2002 N=80 --> 62
- oseltamivir / Generic mfg.
New P2/3 trial: Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One (clinicaltrials.gov) - Mar 5, 2012
P2/3, N=0, Withdrawn, Sponsor: University of Oxford
- | midodrine hydrochloride / Generic mfg.
New P2 trial: FLUMED: Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells (clinicaltrials.gov) - Mar 5, 2012
P2, N=161, Recruiting, Sponsor: Hospices Civils de Lyon
- Trial completion: Effects of Interscalene Brachial Plexus Nerve Blocks on the Hand and Forearm (clinicaltrials.gov) - Mar 5, 2012
P=N/A, N=62, Completed, Sponsor: University of California, San Diego
N=80 --> 62 Recruiting --> Completed
- ||||||| Trial completion, Preclinical: Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly (clinicaltrials.gov) - Mar 4, 2012
P3, N=2654, Completed, Sponsor: Novartis Vaccines
Recruiting --> Completed Terminated --> Completed